Journal of the Association of Nurses in AIDS Care (JANAC)

JANAC Style Guide, July 2021 p.

JANAC Style Guide for Authors and Reviewers

JANAC is edited according to the Publication Manual of the American Psychological

Association (APA, 7

ed.). JANAC modifications to APA format are discussed in this

document. The JANAC Style Guide takes precedence over the APA Manual.

This document provides additional information to the Author Guidelines (available at

http://edmgr.ovid.com/janac/accounts/ifauth.htm) and should be used in conjunction with that

document and the APA Manual.

Table 1. Formatting Your Paper

Item

Requirement

Notes

Comma

Use serial or Oxford

comma

Add a comma before the last item in a series that

appears before the word “and”: Red, white, and

blue.

Font size

12 pt.

Headings

3 levels

See template here:

https://apastyle.apa.org/instructional-

aids/heading-template-professional-paper.pdf

Italics

• Letters used as

statistical symbols

or algebraic

variables (e.g., n =

10; p < .001).

• Anchors of a scale

(e.g., from 1 [poor]

to 5 [excellent] … ).

• Genera, species, and

varieties.

• The introduction of

a new, technical,

key term, or label.

• Some test scores

Do not use italics for foreign phrases and

abbreviations common in English, chemical

terms, non-statistical subscripts to statistical

symbols or mathematical expressions, or for mere

emphasis.

Justification

Left

For all text

Line

Numbering

Continuous

Required for text but not tables or figures. Please

add sequential line numbering to your Word

documents for the main manuscript (text) file.

You will see that the system will also add line

numbers when it creates the PDF of your

JANAC Style Guide, July 2021 p.

submission, but these start over on each page and

the reviewers prefer sequential numbering.

Lists

(a), (b), (c)

1, 2, 3

Bullet points

Use lettered lists for phrases included in a

sentence. Use numbered lists for complete

sentences or paragraphs in a series. Use bullets

instead of numbers to remove an unwarranted

chronology or priority to the items.

Margins

1 inch, all sides

Periods

• 1 space after a

period or other

mark at the end of a

sentence

• U.S. - when used as

an adjective

• et al., e.g.,

• No periods for state

abbreviations or

academic degrees

• Do use a period after in. (inch or inches)

because it could be misread as the word “in”.

• Do not abbreviate the noun, United States.

Made in the United States. It is a U.S. product.

• CO, NY, TX, Washington, DC

• PhD, RN, FAAN

Plural

pronouns or

generic third-

person

singular

pronouns

They, them, their,

theirs

When referring to more than 1 person, and when

referring to 1 person for whom you are not sure of

their preferred pronouns. Only use “he” and “she”

when sure the person uses these pronouns.

Pronouns for

authors

First person

I or We when referring to the authors of the

paper/researchers of the study

Series within

the text

(a), (b), (c), etc.

For a series set off in a list, use numbers or bullet

points

Spacing

• Double space the

lines of text

• No extra lines

between paragraphs

Including the abstract and references; lines in tables

may be single spaced; do not put extra lines before

or after headings

References

See examples here:

https://apastyle.apa.org/instructional-

aids/reference-guide.pdf

Running Head

• 50 characters or less

• Top of each page

• Flush Left

The running head is a shortened version of the

title.

Tables &

Figures

Appended after the

reference list. Should

not be embedded in the

text.

This is JANAC’s style and is contrary to APA 7

edition style.

Note. From APA Manual, 7

edition, 2020

Table 2. Word Choice

Correct Usage

Notes

HIV

• HIV/AIDS is not used in JANAC unless it is part of the

name of an organization or in a referenced document title.

JANAC Style Guide, July 2021 p.

• Use AIDS only when speaking of an AIDS diagnosis or

when in an organization’s formal title, otherwise use HIV,

which is a more inclusive term.

• Do not use “virus” after HIV – it is redundant.

ART, cART

• ART is used rather than HAART on the premise that all

ART should be highly active

• combination antiretroviral therapy (cART) is an accurate

and acceptable alternate term.

Health care

2 words, no hyphen

decision making

decision-making

Hyphenate terms such as “risk-taking” and “decision-making,”

only when the compound precedes the term it modifies (e.g.,

risk-taking behavior, decision-making skills).

People/person living

with HIV (PLWH)

Do not use HIV patient, HIV positive, or HIV-infected person.

“Person without HIV infection” or “uninfected” are preferred;

do not use HIV negative.

Co-infected, co-

infection

Not coinfected and coinfection.

Active voice is preferred

• First-person should be used when referring to the authors’

study (i.e., our study) or when other wording is confusing

(i.e., the current study) or awkward (i.e., the study reported

in this paper).

• First-person pronouns should also be used when (a) citing

direct quotes as a part of qualitative data or in a personal

communication, (b) a first-person pronoun will do a better

job of making a particular point or emphasis, or (c) the use

of a first-person pronoun creates clarity.

Generic names should

be used for drugs

See drug tables below.

mixed method

Method is not plural and the two words are not hyphenated.

Since/because

Do not use “since” when you mean “because.” “Since” denotes

time (e.g., since 1977) and is appropriately used in those

instances.

Numbers and Statistics

Correct Usage

Notes

p = .05, p = .0001,

Lowercase, italic, no leading zero, carry out

to the numeral

1,234, 4,111,222.33

Use commas in numbers with 4 or more

digits

CD4+ T cell

Not CD cell or CD4 cell

CD4+ T cell count

Use [number of cells] CD4+ T cells/mm

xx viral copies/mL

1 day, 3 months, 5 minutes, May 5, 1992, 6

years old, 4 on a 10 scale, $4.32

Use numbers for time, dates, ages, scores

and points on a scale, exact sums of money

JANAC Style Guide, July 2021 p.

More than, less than, at least

Use “more than,” “less than,” and “at least”

in text and use symbols in parentheses (i.e.,

> 18 years of age, < .01, > 100). Do not use

“under” when you mean less than; do not

use “over” when you mean more than.

Note. From APA Manual, 7

edition, 2020

Tables and Figures

Item

Notes

Number of tables/figures allowed

• We accept a combined total of up to 5

tables and figures in feature manuscript

submissions.

• You may include no more than 3 tables

and/or figures per manuscript for non-

feature manuscript submissions

Table/Figure Notes

Use “Note.” at the bottom of the table to

provide additional information.

o Footnote symbols: Use superscript

lowercase letters in the table (

). The

corresponding footnote is set at baseline

followed by a period (a., b., c.).

o Define all abbreviations and acronyms

used in the table at the bottom of the

table. Use “ = ” between the abbreviation

and the expansion; separate

abbreviations with a semicolon; for

example: Note. ART = antiretroviral

therapy; CI = confidence interval.

o Define all abbreviations and acronyms

used in each table even if they have been

defined in the paper or if they are used in

other tables.

Permissions

• If reprinting or adapting any part of a

previously published work, you must

obtain permission from the copyright

holder and include a credit line in the

table/figure note in the format required

by the copyright holder. This includes

your own previously published work and

information/images found on the

internet.

• If the work you are re-using was

published open access or is in the public

domain, you must state this in the note

and include the proper citation.

JANAC Style Guide, July 2021 p.

Citations in text to tables/figures

• The order number for tables and figures

is determined based upon when they are

cited in the text.

• Numbers must be sequential.

• Do not indicate placement in the text

(e.g., Place Table 1 here).

Placement in the manuscript

• Include tables at the end of the

manuscript, after the references or Key

Considerations. They should not be

embedded in the text.

• You may embed small figures in the text

but you must also include a separate file

for each figure in the format in which it

was created (e.g., pptx, TIFF, Excel).

See the Information for Authors for

approved formats. Larger figures should

be appended after the reference list or

Key Considerations and not embedded

in the text.

Borders and Shading

• Avoid shading in tables. It displays well

online but not in print.

• Avoid vertical borders and borders

around each cell in a table.

Figure images

• Images should be provided in a

resolution sufficient for clear viewing

and printing.

Color

• Tables and figures will be displayed in

color online but will be printed in black

and white. Ensure the table/figure is

readable without the color.

Note. See “Table Checklist,” “Figure Checklist,” and examples in the APA 7

edition

Manual.

Abbreviations and Acronyms

• In general, spell out an abbreviation or acronym at first use and place the abbreviation

in parentheses, for example: antiretroviral therapy (ART). After that, use the

abbreviation or acronym consistently throughout the article. If the term is used three

or fewer times in the manuscript, spell it out every time.

• Exceptions: HIV, AIDS, and JANAC are used without having to define them.

• Use “vs.” in parentheses but spell out “versus” in the text.

• See tables below.

Journal of the Association of Nurses in AIDS Care

Approved Acronyms

BIOLOGY AND HEALTH CARE

Acronym

Definition

Acronym

Definition

ABG

arterial blood gas

HSV

herpes simplex virus

ADC

AIDS dementia complex

IL-2

interleukin-2

JANAC Style Guide, July 2021 p.

ADLs

activities of daily living

INH

isoniazid

AIDS

acquired immune deficiency syndrome

Kaposi's sarcoma

ALT

alanine transaminase

LDL

low-density lipoprotein

ANC

absolute neutrophil count

LFT

liver function test

ART

antiretroviral therapy

MAC

Mycobacterium avium complex

ARV

antiretroviral

MTCT

mother-to-child transmission

BMD

Bone mineral density

MTB

Mycobacterium tuberculosis

BMI

body mass index

nPEP

non-occupational post-exposure prophylaxis

BUN

blood urea nitrogen

opportunistic infection

CAM

complementary/alternative medicine

PCP

Pneumocystis jiroveci pneumonia

cART

combination antiretroviral therapy

PCR

polymerase chain reaction

CBC

complete blood count

PEP

post-exposure prophylaxis

CMV

cytomegalovirus

PGL

persistent generalized lymphadenopathy

CNS

central nervous system

PID

pelvic inflammatory disease

CSF

cerebrospinal fluid

PML

progressive multifocal encephalopathy

DOT

directly observed therapy

PPD

purified protein derivative

EBV

Epstein-Barr virus

PrEP

pre-exposure prophylaxis

ELISA

enzyme linked immunosorbent assay

PMTCT

prevention of mother-to-child transmission

HAV

hepatitis A virus

RNA

ribonucleic acid

HBV

hepatitis B virus

RPR

rapid plasma reagin

HBcAB

hepatitis B core antibody

RT-PCR

reverse transcriptase – polymerase chain reaction

HBeAg

hepatitis B e antigen

STD/STI

sexually transmitted disease/infection

HBsAg

hepatitis B surface antigen

TPM-SMX

trimethoprim-sulfamethoxazole/Bactrim

HCV

hepatitis C virus

viral load

HDL

high-density lipoprotein

VZIG

varicella zoster immune globulin

HIV

human immunodeficiency virus

VZV

varicella zoster virus

MISCELLANEOUS

Acronym

Definition

Acronym

Definition

AACRN

Advanced AIDS Certified Registered Nurse

HCP

health care provider

ACRN

AIDS Certified Registered Nurse

IDU

injection drug user/use

AI/AN

American Indian/Alaska Native

IPV

intimate partner violence

CBA

capacity building assistance

MSM

men who have sex with men

case manager/case management

PLWH

people living with HIV

CQI

continuous quality improvement

quality assurance

CSW

commercial sex worker

quality improvement

LGBTQ

lesbian, gay, bisexual, transgender, questioning/queer

QoL

quality of life

JANAC Style Guide, July 2021 p.

ORGANIZATIONS AND PROGRAMS

Acronym

Definition

Acronym

Definition

ACA

Patient Protection and Affordable Care

Act

FQHC

Federally Qualified Healthcare Center

ACTG

AIDS Clinical Trials Group

HIPAA

Health Insurance Portability and Accountability

Act

ACTIS

AIDS Clinical Trials Information

Service

HIVATIS

HIV/AIDS Treatment Information Service

ACTU

AIDS Clinical Trials Unit

HMA

Health Maintenance Alliance

ADA

Americans with Disabilities Act

HOPWA

Housing Opportunities for People with AIDS

ADAP

AIDS Drug Assistance Program

HRSA

Health Resources and Services Administration

AETC

AIDS Education and Training Center

HVTN

HIV Vaccine Trials Network

AHEC

Area Health Education Center

IHS

Indian Health Service

AmFAR

American Foundation for AIDS

Research

IRB

institutional review board

ANAC

Association of Nurses in AIDS Care

MACS

Multicenter AIDS Cohort Study

ASO

AIDS service organization

NGO

non-government organization

CAB

community advisory board

NHAS

National HIV/AIDS Strategy

CAEAR

Coalition

Communities Advocating Emergency

AIDS Relief Coalition

NIAID

National Institute of Allergy and Infectious

Disease

CBO

community-based organization

NIH

National Institutes of Health

CDC

Centers for Disease Control and

Prevention

N/SEP

needle/syringe exchange program

CFAR

Center for AIDS Research

OSHA

Occupational Safety and Health Administration

CHC

community health center

PACTG

Pediatric AIDS Clinical Trials Group

CMS

Center for Medicare and Medicaid

Services

PHS

Public Health Service

CPCRA

Community Programs for Clinical

Research on AIDS

RWP/

RWHAP

Ryan White Program/

Ryan White HIV/AIDS Program

DHHS

Department of Health and Human

Services

SAMHSA

Substance and Mental Health Services

Administration

EMA

Eligible Metropolitan Area

UNAIDS

Joint United Nations Programme on HIV/AIDS

FDA

Food and Drug Administration

WHO

World Health Organization

JANAC Style Guide, July 2021 p.

ANTIRETROVIRAL MEDICATIONS

Acronym

Medication

Acronym

Medication

Nucleoside/Nucleotide Reverse Transcriptase

Inhibitors (NTTIs)

Non-Nucleoside Reverse Transcriptase Inhibitors

(NNRTIs)

3TC

lamivudine/Epivir

DLV

delavirdine/Rescriptor

ABC

abacavir/Ziagen

DOR

doravirine/Pifeltro

AZT

former name for ZDV

EFV

efavirenz/Sustiva

d4T

stavudine/Zerit

ETV

etravirine/Intelence

ddI

didanosine/Videx

NVP

nevirapine/Viramune

FTC

emtricitabine/Emtriva

RPV

rilpivirine/Edurant

TAF

Tenofovir

alafenamide/Vemlidy

Entry Inhibitors

TDF

tenofovir disoproxil

fumarate/Viread

Post-Attachment Inhibitor

or Monoclonal Antibody

ibalizumab-uiyk (Trogarzo)

ZDV

zidovidine/Retrovir

MVC (CCR5 antagonist)

maraviroc/Selzentry

ENF/T-20 (Fusion

inhibitor)

enfuvirtide/Fuzeon

Fixed Dose Combination NRTIs

Integrase Strand Transfer Inhibitors (INSTI)

ABC + 3TC

Epizicom

BIC

bictegravir (combined with

other drugs as Biktarvy)

AZT + 3TC

Combivir

DTG

dolutegravir/Tivicay

AZT + 3TC + ABC

Trizivir

EVG

elvitegravir/Vitekta

TDF + FTC

Truvada

RAL

raltegravir/Isentress

Boosting Agents

Protease Inhibitors (PIs)

COBI

cobicistat/Tybost

ATV

atazanavir/Reyataz

RTV

ritonavir/Norvir

DRV

darunavir/Prezista

Single Tablet Fixed Dose Multi-Class Agents

FPV

fosamprenavir/Lexiva

TDF + FTC + EFV

Atripla

IDV

indinavir/Crixivan

BIC + FTC + TAF

Biktarvy

LPV/r

lopinavir + ritonavir/Kaletra

3TC + TDF

Cimduo

NFV

nelfinavir/Viracept

AZT + 3TC

Combivir

RTV

ritonavir/Norvir

TDF + FTC + RPV

Complera

SQV

saquinavir/Invirase

Fortovase

DOR + TDF + 3TC

Delstrigo

TPV

tipranavir/Aptivus

FTC + TAF

Descovy

DTG + 3TC

Dovato

ABC + 3TC

Epizicom

ATV + COBI (ATZc)

Evotaz

EVG + COBI + FTC + TAF

Genvoya

DTG + RPV

Juluca

LPV (LPV/r) + RTV

Kaletra

FTC + RPV + TAF

Odefsey

DRV + COBI (DRVc)

Prezcobix

EVG + COBI + FTC + TDF

Stribild

™

EFC + 3TC + TDF

Simfi

JANAC Style Guide, July 2021 p.

DRV + COBI + FTC + TAF

Symtuza

ABC + DTG + 3TC

Triumeq

AZT + 3TC + ABC

Trizivir

TDF + FTC

Truvada

The following page provides an example of a title page:

JANAC Style Guide, July 2021 p.

Example Title Page

Supporting authors in developing countries: The Zimbabwe experience

Chris Kudzai, PhD, MSW

Kristen Overstreet, BA

Lucy Bradley-Springer, PhD, RN, ACRN, FAAN

Chris Kudzai, PhD, MSW, is a Professor, College Health Sciences, University of Zimbabwe,

Harare, Zimbabwe. Kristen Overstreet*, BA, is Managing Editor, Origin Editorial, LLC,

Austin, Texas, USA ([email protected]). Lucy Bradley-Springer, PhD, RN,

ACRN, FAAN, is an Associate Professor Emerita, University of Colorado Denver, Aurora,

Colorado, USA.

*Corresponding Author: Kristen Overstreet: [email protected]

Disclosures

The authors report no real or perceived vested interests related to this article that could be

construed as a conflict of interest.

Chris Kudzai reported receiving lecture fees from XYZ International. Kristen Overstreet

disclosed consulting fees from 123 Inc. Lucy Bradley-Springer reported no financial interests

or potential conflicts of interest.

Acknowledgments

This study was funded by ABC Corporation and grant #1-234-5678 (PI: Chris Kudzai) from

DEF Foundation. The authors acknowledge Florence Tatenda and Albert Shamiso for their

assistance in data collection and transcription.

Clinical Trial Registration number: xxx

Author Contributions

All authors on this paper meet the four criteria for authorship as identified by the

International Committee of Medical Journal Editors (ICMJE); all authors have contributed to

the conception and design of the study, drafted or have been involved in revising this

manuscript, reviewed the final version of this manuscript before submission, and agree to be

accountable for all aspects of the work. Specifically, using the CRediT taxonomy, the

specific contributions of each author is as follows: Conceptualization & Methodology: C.

Kudzai, K. Overstreet, L. Bradley-Springer; Formal Analysis: C. Kudzai, L. Bradley-

Springer; Funding acquisition: K. Overstreet; Investigation: C. Kudzai, K. Overstreet; Project

administration: K. Overstreet; Supervision: K. Overstreet; Validation: L. Bradley-Springer;

Writing – original draft: C. Kudzai, L. Bradley-Springer; Writing/Revising – K. Overstreet.

Key words: Provide 3 to 6 key words. Key words related to the content of the manuscript

should be listed in alphabetical order and separated by commas; do not capitalize key terms

unless they are proper names.

• Key words should follow the abstract for features, briefs, case studies, and

commentaries, and be placed at the end of the title page for guest editorials, media

reviews, and letters to the editor. Include the design type as a key word for feature

JANAC Style Guide, July 2021 p.

(research and review) articles.

• Note: for research papers, key words should include method (e.g., practice improvement

project, RCT, phenomenological study); population (e.g., transmen, women, Hispanic

youth); and key variables (e.g., health literacy, stigma, substance use, race).

JANAC Style Guide, July 2021 p.

References

Item

Notes

Left justify the text.

Use the hanging indent (½ inch) for all

references.

Double space throughout.

Spell out all periodical names.

Do not use widow and orphan control.

Do not underline anywhere in the reference

list.

Do not abbreviate or use acronyms for the

names of organizations.

Use italics for periodical names and volume

numbers, book titles, titles of references

retrieved online, and journal names.

Author names should have a comma

between the last name and the author’s

initials. A comma is used before an

ampersand, even if there are only 2 authors.

Jimenez, G.

Begay, A., & Patrick, J.

The notation et al. is not used in reference

lists.

• If a manuscript has as many as 20

authors, list all 20 with an ampersand

(&) between the nineteenth and

twentieth authors.

• If a reference has 21 or more authors,

list the first 19 authors, then use an

ellipses (…) to represent authors

between the 19th and final author. After

the ellipses, list the final author’s last

name and initials. The final author is the

final person in the list, not a program

name or the name of a

group/panel/board.

Titles in the reference list

Capitalize only the first word, the first word

after a colon, and proper nouns.

Retrieval dates

If a citing an online source that is likely to

change, include a retrieval date with the

reference so the reader knows what you

accessed may not be the same as what they

subsequently access.

No date

If a source does not have a publication or

posting date, use “n.d.” to represent “no

date.”

DOI and URL

• Include DOI numbers, when available,

for all references. Note: DOI numbers

all begin with the number 10. Use this

format – doi:10.0000XXX-res

• Provide a URL if

o a DOI is not available

o the work is not from an

JANAC Style Guide, July 2021 p.

academic research database

o the URL is still working and

takes the reader directly to

the source you are citing.

• For works from databases that publish

works of limited circulation or original,

proprietary material, include the name of

the database or archive and the URL of

the work. If a login is required to access

the work, provide the URL to the

database home page.

• Provide the DOI or URL as a live

hyperlink.

• For DOI numbers – use the link format

http://dx.doi.org/xxxxxxx (xxxxxxx

would be the source’s specific number)

and not DOI:xxxxxxx

Note. From APA Manual, 7

edition, 2020

JANAC Style Guide, July 2021 p.

Examples of references using APA 7

edition format with JANAC Style Guide revisions

In-text Citations

One or two authors in text

Swanson (2020) said . . . Webel and Relf

(2019) found . . .

One or two authors in parentheses in text

(Swanson, 2020; Webel & Relf, 2019)

Three or more authors in text

Johnson et al. (2018) indicated . . .

Three or more authors in parentheses in text

(Johnson et al., 2018)

Cite the year each time you cite the

reference, even in the same paragraph

List multiple citations within the same

parentheses in alphabetical order

(Overstreet, 2017; Relf et al., 2019;

Swanson & Webel, 2015)

Citation is abbreviated to the last name of

the first author et al., and year, but can then

be confused with another reference in the

list — include the second author’s last

name, and then the third, etc., until there is

no confusion and the reader can clearly see

the reference you are citing. Include a

comma after the last author’s name, before

the “et al.”.

(Chen, Moon, Gonzalez, et al., 2018)

Multiple citations to works written by

different authors with the same last name —

use each of those authors’ first initials to

avoid confusion.

(C. F. Wang, 2013; T. A. Wang et al., 2018)

Multiple citations to works written by the

same authors (all the same authors, in the

same order) and publication year — add a

letter to each reference, starting with the

first reference cited.

(Martinez et al. 2016a; Martinez et al.,

2016b)

Group authors (e.g., American

Psychological Association) can be

abbreviated if used more than 3 times in the

paper. Provide the full name on first

mention, followed by the abbreviation.

• Appearing first in text: American

Psychological Association (APA, 2017).

• Appearing first in parenthetical citation:

(American Psychological Association

[APA], 2017)

• Use the full name in the reference list.

Websites, periodicals, software, and apps

General mention, no specific information –

provide the name and URL in parentheses.

For example, . . . Qualtrics

(www.qualtrics.com) . . .

Direct Quotations

• Provide the page number(s) for the

quoted material, after the year in the

citation (e.g., Mutombo, 2011, p. 25).

• If no page number is available, use the

heading/section name and/or paragraph

number in place of the page number in

the citation (e.g., Agarwal, 2019, para. 4;

Mutombo, 2021, Methods section; Xin

2017, Methods section, para. 4).

Note. From APA Manual, 7

edition, 2020

JANAC Style Guide, July 2021 p.

References

Bradley-Springer L. (2013). Grace [Video]. Retrieved from

http://www.youtube.com/watch?v=n9UxcwxNmfw

Haukoos, J., Hopkins, E., Bucossi, M., Lyons, M., Rothman, R., White, D., & Thrun, M.

(2014, March 5). Validation of the refined Denver HIV Risk Score using a national

HIV testing cohort. Poster presented at CROI 2014 in Boston, MA, USA.

Joint United Nations Programme on HIV/AIDS. (2014). 90-90-90. Retrieved from

http://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf

Kwong, J., & Bradley-Springer, L. (2014). Infection and human immunodeficiency virus

infection. In S.L. Lewis, M.M. Heitkemper, S.R. Dirksen, & L. Bucher (Eds.),

Medical-surgical nursing: Assessment and management of clinical problems (9

ed.),

pp. 226-246. St. Louis, MO: Mosby Elsevier.

Myers, J., Bradley-Springer, L., Dufour, M.-S.K., Koester, K., Beane, S., Warren, N., Cook,

P., Mark, L., Kemppainen, J., Bielser, H., Young, B., Romness, G., Wang, T.A., Xin,

C.F., Shamseer, L., Roberts, J., Maher, J., Mansoor, P., Earlyday, M., Lovejoy, B., . . .

Frank, L.R. (2012). Supporting integration of HIV testing into primary care settings.

American Journal of Public Health, 102(6), e25-e32. doi:10.2105/AJPH.2012.300767

Office of National AIDS Policy. (2010). National HIV/AIDS strategy for the United States.

Retrieved from http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf

Polit, D. F., & Beck, C. T. (2008). Nursing research: Principles and methods. Philadelphia,

PA: Lippincott Williams & Wilkins.

Note: Use only the references

you need to support

assertions in your paper.

Don’t pad the reference list.

JANAC Style Guide, July 2021 p.

Steward, W.T., Koester, K.A., & Fuller, S.M. (in press). Shaping the patient-centered medical

home to the needs of HIV Safety Net patients: The impact of stigma and the need for

trust. Journal of the Association of Nurses in AIDS Care, [Online ahead of print].

doi:10.1016/j.jana.2018.06.005